Tag Archives: TDS

Top Stocks To Buy Right Now

Source: Stock Photo

Although it’s not a certainty yet, BP (NYSE:BP) says it is seriously considering spinning off its pipeline assets into an MLP. It will probably be called BP Midstream Partners, and would include its Gulf Coast and Midwest pipeline assets.

According to BP, an IPO would provide the company “the opportunity to grow its pipeline business, while also giving investors new venues to find value.”

There are several things to consider in regard to this announcement, including the impetus behind the idea, how it will impact BP’s performance and share price, and the way it views its other businesses.

Top Stocks To Buy Right Now: Telephone and Data Systems, Inc.(TDS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Telephone & Data Systems, Inc. (NYSE: TDS) is projected to report its quarterly earnings at $0.10 per share on revenue of $1.26 billion.

    PharMerica Corporation (NYSE: PMC) is estimated to report its quarterly earnings at $0.43 per share on revenue of $509.45 million.

Top Stocks To Buy Right Now: DBV Technologies S.A.(DBVT)

Advisors’ Opinion:

  • [By Lisa Levin]

    DBV Technologies SA – ADR (NASDAQ: DBVT) shares dropped 46 percent to $26.11 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.

  • [By Monica Gerson]

    DBV Technologies SA ADR (NASDAQ: DBVT) is expected to post a quarterly loss at $0.60 per share.

    Northern Technologies International Corp (NASDAQ: NTIC) is projected to post its quarterly earnings.

  • [By Paul Ausick]

    DBV Technologies SA (NASDAQ: DBVT) dropped about 53.5% Monday to post a new 52-week low of $22.33 after closing at $48.07 on Friday. The stock’s 52-week high is $50.57. Volume of around 12 million was about 60 times the daily average. The French drug maker’s peanut allergy treatment failed a phase 3 study.

Top Stocks To Buy Right Now: Infinity Pharmaceuticals, Inc.(INFI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.

  • [By Lisa Levin]

    Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares dropped 70 percent to $1.32. Infinity announced plans to cut 21 percent of the workforce. The company also reported that DYNAMO Phase 2 monotherapy study evaluating the efficacy and safety of duvelisib met its primary endpoint.

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.

Top Stocks To Buy Right Now: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of Tesaro (TSRO) are soaring today after the biotech company reported positive data for its treatment of ovarian cancer over the weekend. Credit Suisse analyst Alethia Young and team contend that “M&A remains in focus” for Tesaro following the data:

    Getty Images

    We are increasing our target price to $122 from $90 as we move to an M&A DCF valuation. We were at ESMO this weekend, and we believe the big takeaway on Tesaro data is that it works broadly in all 2L ovarian populations and safety looks solid. We also think the robustness of this data bodes well from PRIMA and QUADRA but are maintaining our POS here. We have looked at our model and also adjusted durations in first-line. We think Tesaro remains one of the most attractive and de-risked cancer assets in our landscape and the company has been cited in major press sources as a takeout target (Bloomberg, Investor Business Daily).

    We think M&A remains in focus for Tesaro. Our M&A DCF valuations range from $122 to $157 by our model. We have also built models for other cancers like NSCLC, SCLC, prostate, and others where PARP might be impactful. We assume 0% POS for now but we conservatively see at least another $1B in sales from PARP expansion. Tesaro has been cited in the press as a potential M&A target and is a company we frequently hear mentioned as a target from our conversations. We think the demand for late stage oncology assets is high, especially in the PARP space given the potential for activity across a range of tumors. For a large Pharma player who already has an oncology salesforce and large R&D infrastructure we could see SG&A synergies of 50-75% and R&D synergies of 15-30%. In our base case TSRO P&L we model a tax rate of 30% so there could be synergies here as well. Two additional key swing factors which might be included in a CVR are how much expansion from PARP in other cancers and immuno-oncology…

    Ex M&A,

  • [By Todd Campbell]

    Tesaro’s (NASDAQ:TSRO)ovarian cancer drug, niraparib, will begin competing for prescriptions earlier than expected. Niraparib, which will be sold under the brand name Zejula, notched FDA approval on Monday, more than three months ahead of its June 30 decision date. The early approval setsTesaro up for a fierce battle for market share withAstraZeneca (NYSE:AZN)and Clovis Oncology (NASDAQ:CLVS), both of which market drugs that work similarly to Zejula.

  • [By Ben Levisohn]

    Guggenheim’s Tony Butler and Kaitlin Sandor argue that Gilead Sciences (GILD) should buy Syndax Pharmaceuticals (SNDX), Corvus Pharmaceuticals (CRVS), and Tesaro (TSRO) to solve its problem of slowing sales:

  • [By George Budwell]

    Unfortunately for Clovis and its shareholders, though, Astra’s Lynparza is currently underpriority review with the FDA as a maintenance therapy in ovarian cancer, andTesaro’s (NASDAQ:TSRO)rival PARP inhibitor Zejula gained an early approval– along with afar broader label than Rubraca — just this week.

  • [By Ben Levisohn]

    Look out below! Shares of Tesaro (TSRO) have dropped more than 10% this afternoon after AstraZeneca (AZN) released stronger-than-expected Phase 3 trial data on a its ovarian cancer treatment.

    Agence France-Presse/Getty Images

    The Street’sAdam Feuerstein has the details on AstraZeneca’s strong data and its impact on Tesaro:

    AstraZeneca’s (AZN) PARP inhibitor Lynparza delayed the recurrence of ovarian cancer by more than two years compared to a placebo, according to results from a phase III study presented Tuesday.

    The strong benefit observed with Lynparza as ovarian cancer maintenance therapy exceeded investor expectations and bolsters AstraZeneca against a competing PARP inhibitor from Tesaro (TSRO).

    Feuerstein also notes that AstraZeneca’s data could be good newsClovis Oncology (CLVS), which also had a PARP inhibitor approved recently, if it means that its drug could work as well as Astra’s.

    In February, Leerink cut Tesaro, arguing that the rally in its shares due to a potential takeover had run too far. Will it still be a takeover target?

    Shares of Tesaro have dropped 14% to $148.01 at 3:28 p.m. today, while AstraZeneca has gained 1.1% to $30.41, and Clovis Oncology has jumped 9.8% to$66.55.

    UPDATE:Piper Jaffray’sSteven Breazzano andJoshua Schimmer note that the AstraZeneca data shows that PARPs are “more similar than different.” They explain:

    This afternoon AstraZeneca (covered by PJC analyst Richard Purkiss) reported the detailed results from the SOLO-2 maintenance study of Lynparza in 2L+ ovarian cancer. The detailed data highlights a PFS benefit of 14 months (investigator assessed, and primary endpoint) and 25 months (blinded central review) over placebo, and favorable hazard ratio of 0.30 and 0.25, respectively, confirming our view that the PARP’s are more similar than different. As such, we believe this provides a favorable readth

  • [By Todd Campbell]

    The PARP battle is on. Following news that AstraZeneca’s (NYSE:AZN) PARP-inhibiting cancer drug Lynparza delivered a big win in phase 3 studies, all eyes now shift to how a potential Food and Drug Administration approval for Lynparza will reshape the commercial opportunity for competitor Tesaro Inc. (NASDAQ:TSRO).

Top Stocks To Buy Right Now: Critical Elements Corporation (CRECF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    ILC reminds me of Critical Elements [TSXV:CRE] (OTCQX:CRECF) having five projects (CRE has 11), and also of Galaxy Resources (ASX:GXY) (OTCPK:GALXF) by being diversified across brine and spodumene and across three continents. Also some similarity with Neo Lithium’s (OTC:NTTHF) [TSXV:NLC] early stage Argentinean brine project which I recently wrote about here. However, ILC trades at a much smaller market cap of US$8m to that of Critical Elements (US$85m) or Galaxy Resources (US$724m). This is partly due to ILC giving away significant percentages of their projects, and because they are still in the early stages of development.

Best Value Stocks To Own Right Now

HanesBrands (NYSE: HBI) stock price has come under pressure, reaching 52-week lows in the past week, which has sparked my interest to evaluate the company. HanesBrands reported revenue and earnings in-line with analyst consensus estimates for the third quarter; however, the company provided slightly lower than expected guidance for the fourth quarter which was one of the perceived reasons for the sell-off. In this article, I dive further into the financial statements to evaluate the company’s financial health and growth, address investor concerns, and provide my perspective on the company moving forward. In my opinion, and from my findings described in the article below, HanesBrands appears to be undervalued and the stock price is fairly attractive at these levels. I have started adding to a new position in the company at $19 a share, seeing the recent sell-off as a reasonable buying opportunity.

Snapshot of HanesBrands Stock Price Year-to-Date

With the release of third quarter financial results and fourth quarter guidance, the company’s stock price has further declined by 15%. In the past week, the stock has traded around 52-week lows of $19 per share.

Best Value Stocks To Own Right Now: Polaris Industries Inc.(PII)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Supply could come from any number of industry players, including Winnebago Industries, Inc. (NYSE: WGO), Thor Industries, Inc. (NYSE: THO), Polaris Industries Inc. (NYSE: PII) and Camping World Holdings Inc (NYSE: CWH). However, whether it comes from existing inventory and whether suppliers can meet the demand are yet to be seen.

  • [By Steve Symington]

    Polaris Industries Inc.(NYSE:PII)announced first-quarter 2017 results on Tuesday morning, punctuated by a narrower-than-expected net loss, improving retail sales in North America, and stabilizing off-road vehicle (ORV) market share.

Best Value Stocks To Own Right Now: Telephone and Data Systems, Inc.(TDS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Telephone & Data Systems, Inc. (NYSE: TDS) is projected to report its quarterly earnings at $0.10 per share on revenue of $1.26 billion.

    PharMerica Corporation (NYSE: PMC) is estimated to report its quarterly earnings at $0.43 per share on revenue of $509.45 million.

Best Value Stocks To Own Right Now: BiondVax Pharmaceuticals Ltd.(BVXV)

Advisors’ Opinion:

  • [By Chris Lange]

    BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) reported that the scientific journal “Vaccine” published an article citing results from its flu vaccine. The “Vaccine” article, Back to the future: Immunization with M-001, reports that blood plasma samples from people who received M-001 in 2011 (as part of BiondVax’s BVX-005 clinical trial in the elderly) showed significantly increased protective antibodies against the new epidemic 2014/15 flu strain (A/Swiss) – a strain which did not exist when M-001 was administered to the BVX-005 participants.

Best Value Stocks To Own Right Now: Dillard's, Inc.(DDS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores spiking twice in 2013 and then, along withlarge cap Macy’s, Inc (NYSE: M) and mid capDillard’s, Inc (NYSE: DDS), having large declines that may or may not have leveled offwhilesmall cap J C Penney Company Inc (NYSE: JCP) has lost most of its value:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores having two spikes while it along withlarge cap Macy’s, Inc (NYSE: M) and mid capDillard’s, Inc (NYSE: DDS) have posted large declines last year that may or may not have leveled off andsmall cap J C Penney Company Inc (NYSE: JCP) has at least stopped the bleeding:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores spiking twice in 2013 and has been falling off for a longer period of time thanlarge cap Macy’s, Inc (NYSE: M) andsmall capDillard’s, Inc (NYSE: DDS)whilesmall cap J C Penney Company Inc (NYSE: JCP) was crushed much earlier:

  • [By Peter Graham]

    Small cap department store stock Dillard’s, Inc (NYSE: DDS), whos potential peers includemid caps Macy’s, Inc (NYSE: M) and Nordstrom, Inc (NYSE: JWN) and small cap J C Penney Company Inc (NYSE: JCP), is the most shorted stock on the NYSE with short interest of 60.80% according to Highshortnterest.com.

Best Value Stocks To Own Right Now: Student Transportation Inc(STB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Student Transportation Inc (NASDAQ: STB) is estimated to post its quarterly earnings at $0.04 per share on revenue of $167.40 million.

    Exar Corporation (NYSE: EXAR) is projected to post its quarterly earnings at $0.09 per share on revenue of $38.38 million.

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested shorting small cap school bus transportation services stockStudent Transportation (NASDAQ: STB):

Hot Heal Care Stocks To Invest In Right Now

Thousands of former enrollees at Trump University are one step closer to getting back at least some of their money.

More than 3,700 of them have filed claims as part of last year’s $25 million settlement agreed to by President Donald Trump, according to an attorney for the plaintiffs in the case. About 7,000 former students were eligible to submit claims, but the deadline to file was March 6.

If the court approves the settlement, former students are projected to receive back about 80% of the money they spent on live seminars or mentorships from the now-defunct, real estate education program, says Rachel Jensen, the class counsel for students nationwide.

The settlement brings the possible closure of three lawsuits that claimed Trump University defrauded students and threatened to drag Trump into court early into his presidency.

A court hearing will be held on March 30 to decide whether to approve the settlement, though one risk is a late challenge from a former student. Sherri B. Simpson of Ft. Lauderdale, Florida filed an objection to the settlement with U.S. District Judge Gonzalo Curiel in San Diego, where the cases have been consolidated.

Hot Heal Care Stocks To Invest In Right Now: Fogo de Chao, Inc.(FOGO)

Advisors’ Opinion:

  • [By Monica Gerson]

    Fogo De Chao Inc (NASDAQ: FOGO) is expected to post its quarterly earnings at $0.28 per share on revenue of $76.80 million.

    Constellium NV (NYSE: CSTM) is estimated to report its quarterly earnings at $0.06 per share on revenue of $1.18 billion.

Hot Heal Care Stocks To Invest In Right Now: SM Energy Company(SM)

Advisors’ Opinion:

  • [By Andrew Efimoff]

    WTI crude oil plunged 3.11 percent on Friday to $48.99 a barrel. Below are the biggest energy losers for the day:

    California Resources Corporation (NYSE: CRC): -19.22%
    Dynamic Materials (NASDAQ: BOOM): -12.39%
    Clayton Williams Energy (NYSE: CWEI): -11.45%
    Dynergy (NYSE: DYN): -11.91%
    EP Energy Corporation (NYSE: EPE): -11.20%
    Mexco Energy (NYSE: MXC) -10.90%
    Whiting Petroleum (NYSE: WLL) -10.79%
    Southwestern Energy Company (NYSE: SWN) -10.79%
    SM Energy Company (NYSE: SM) -10.38%
    Real Goods Solar (NASDAQ: RGSE) -10.34%

    Posted-In: Commodities After-Hours Center Markets Movers

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Friday. Top gainers in the sector included Superior Energy Services, Inc. (NYSE: SPN), Panhandle Oil and Gas Inc. (NYSE: PHX), and SM Energy Co (NYSE: SM).

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday's regular session.

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Monday. Top gainers in the sector included Helix Energy Solutions Group Inc (NYSE: HLX), SM Energy Co (NYSE: SM), and Ecopetrol SA (ADR) (NYSE: EC).

  • [By Lisa Levin]

    On Wednesday, the energy sector proved to be a source of strength for the market. Leading the sector was strength from SM Energy Co (NYSE: SM) and W&T Offshore, Inc. (NYSE: WTI).

Hot Heal Care Stocks To Invest In Right Now: Diamondrock Hospitality Company(DRH)

Advisors’ Opinion:

  • [By Monica Gerson]

    DiamondRock Hospitality Company (NYSE: DRH) is projected to post its quarterly earnings at $0.18 per share on revenue of $218.42 million.

    Weyerhaeuser Co (NYSE: WY) is expected to report its quarterly earnings at $0.20 per share.

Hot Heal Care Stocks To Invest In Right Now: Telephone and Data Systems, Inc.(TDS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Telephone & Data Systems, Inc. (NYSE: TDS) is projected to report its quarterly earnings at $0.10 per share on revenue of $1.26 billion.

    PharMerica Corporation (NYSE: PMC) is estimated to report its quarterly earnings at $0.43 per share on revenue of $509.45 million.

Hot Gold Stocks To Watch Right Now

General Motors has announced that it plans to stop selling Chevrolet brand cars in India at the end of 2017. The company currently runs two production facilities in the country. It will keep the Talegaon facility operational and use it to export vehicles to Mexico and South America, while selling the Halol facility to Chinese joint venture partner SAIC group. The move comes after GM’s efforts at expanding its market share in the country failed to make much traction.

India is expected to surpass Japan as the third biggest auto market in the next decade. India has an extremely low vehicle penetration rate, with only 32 vehicles per 1,000 people as of 2015. This means that there is considerable room for the auto market to grow and, according to Goldman Sachs, vehicle sales could double from 3 million last year by 2025. However, there are costs to capturing this growth that General Motors isn’t willing to take on.

The auto maker developed a $5 billion investment plan along with SAIC Motor. Under this plan, the company planned to manufacture around 2 million vehicles a year and sell them in Mexico, South America, China, and India. In 2015, GM set a target of increasing its market share in India to 3% by 2020. Instead, its market share declined below 1% in the year ended March 31, while the market grew by 9% to cross the 3 million unit mark. This led GM to reconsider its strategy, as it had limited options in the country.

Hot Gold Stocks To Watch Right Now: U S Concrete, Inc.(USCR)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, basic materials shares fell 0.36 percent. Meanwhile, top losers in the sector included US Concrete Inc (NASDAQ: USCR), down 10 percent, and Commercial Metals Company (NYSE: CMC), down 4 percent.

  • [By WWW.THESTREET.COM]

    Coming up in tonight’s episode of Mad Money: Cramer interviews Bill Sandbrook, CEO of U.S. Concrete (USCR)  and focuses on opportunities for Xilinx (XLNX) .  Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

  • [By Lisa Levin]

    In trading on Friday, basic materials shares fell 0.73 percent. Meanwhile, top losers in the sector included US Concrete Inc (NASDAQ: USCR), down 8 percent, and Seabridge Gold, Inc. (USA) (NYSE: SA), down 5 percent.

Hot Gold Stocks To Watch Right Now: ZAIS Group Holdings, Inc.(ZAIS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 42 percent to $3.22. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 48 percent to $3.35. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.

Hot Gold Stocks To Watch Right Now: Telephone and Data Systems, Inc.(TDS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Telephone & Data Systems, Inc. (NYSE: TDS) is projected to report its quarterly earnings at $0.10 per share on revenue of $1.26 billion.

    PharMerica Corporation (NYSE: PMC) is estimated to report its quarterly earnings at $0.43 per share on revenue of $509.45 million.

Hot Gold Stocks To Watch Right Now: Vince Holding Corp.(VNCE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Vince Holding Corp (NYSE: VNCE) were down around 41 percent to $0.800. Vince Holding reported a Q4 loss of $162.1 million on revenue of $63.9 million.

  • [By Peter Graham]

    Small cap upscale apparel brandretailer Vince Holding Corp (NYSE: VNCE) reported Q1 2017 financial results before the market opened this morning. Net sales decreased 14.2% to $58.0 million as wholesale segment sales decreased 20.9% to $35.4 million, primarily due to a reduction in full-price orders as a result of the elimination of the Companys summer delivery, and asdirect-to-consumer segment salesfell 1.0% to $22.6 million. Comparable sales decreased 5.7%, including e-commerce sales, due to a decrease in average order value.

  • [By Lisa Levin]

    Shares of Vince Holding Corp (NYSE: VNCE) were down around 15 percent to $3.67. Vince Holding projects full-year sales and EPS to come in at or below the low end of its earlier issued outlook.

top stocks invest now

After falling by nearly 7% year-over-year in July, the third worst drop since 2009, wholesale sales expanded by nearly 7% in August, the highest gain in almost two years. As with factory orders, however, there are seasonal effects to consider given these are unadjusted comparisons. Blended together, cumulatively wholesale sales for both July and August were down about 1%. Seasonally-adjusted, wholesale sales were up in August just slightly more than they were down in July. Year-over-year adjusted, sales were flat.

Wholesale inventory actually declined year-over-year (NSA) in August. That was the first negative annual change since June 2010. As the sales decline has moderated this year, the drag of inventory has as well. Clearly the supply chain is adjusting to the new environment of this phase of the “rising dollar.” Despite more outward caution about inventory, and thus economy, overall levels still remain seriously elevated.

Click to enlarge
Click to enlarge

top stocks invest now: NCI, Inc.(NCIT)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Information technology company NCI Inc (NASDAQ: NCIT) reported its $283 million sale to H.I.G. Capital Management for $20 per share in cash.

    9. Allied World Assurance

    The insurance firms of Allied World Assurance Company Hldgs Ltd (NYSE: AWH) and Fairfax Financial extended the offering period for purchase of outstanding Allied World shares from June 30 to July 5.

top stocks invest now: Telephone and Data Systems, Inc.(TDS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Telephone & Data Systems, Inc. (NYSE: TDS) is projected to report its quarterly earnings at $0.10 per share on revenue of $1.26 billion.

    PharMerica Corporation (NYSE: PMC) is estimated to report its quarterly earnings at $0.43 per share on revenue of $509.45 million.

top stocks invest now: Intellipharmaceutics International Inc.(IPCI)

Advisors’ Opinion:

  • [By Lisa Levin]

    IntelliPharmaCeutics Intl Inc (USA) (NASDAQ: IPCI) shares dropped 45 percent to $1.38 as the company disclosed that a FDA panel voted against approving the company’s NDA for Rexista™ abuse-deterrent oxycodone hydrochloride extended release tablets.

top stocks invest now: Tree.com Inc.(TREE)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Coming up on this episode of Mad Money: Cramer interviews United Technologies (UTX) CEO Greg Hayes; and Doug Lebda, CEO of LendingTree (TREE) . Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

  • [By Lisa Levin]

    Shares of Lendingtree Inc (NASDAQ: TREE) got a boost, shooting up 16 percent to $212.90. LendingTree reported Q2 adjusted earnings of $0.90 per share on sales of $152.8 million. The company also raised its FY17 outlook.

  • [By Douglas A. McIntyre]

    Many of the sponsors of Bill O’Reilly’s Fox show, “The O’Reilly Factor,” have cancelled ads in the wake of a sexual harassment scandal. However, two mainstream advertisers continue to support O’Reilly online via ads on his Bill O’Reilly website. Based on observations over the past 24 hours, these include LendingTree Inc. (NASDAQ: TREE) and the Hefty division of Reynolds Consumer Products.

top stocks invest now: QCR Holdings Inc.(QCRH)

Advisors’ Opinion:

  • [By Keith Fitz-Gerald]

    My favorite at the moment is QCR Holdings Inc. (NasdaqGM:QCRH).

    Founded in 1993 and headquartered in Moline, IL, the bank has a strong regional lending base in Illinois and Iowa that should grow in line with the broader national economy. I particularly like the fact that the bank considers itself relationship-driven at a time when trust is in short supply.

top stocks invest now: region(DGLD)

Advisors’ Opinion:

  • [By Jim Robertson]

    The VelocityShares 3x Inverse Gold ETN (NASDAQ: DGLD) seeks to provideshort exposure to three times (3x) the daily performance of theS&P GSCI Gold Index. As with UGLD, DGLD would be doing this viafutures contracts.